Does the engagement of clinicians and organisations in research improve healthcare performance: a three-stage review

A Boaz, S Hanney, T Jones, B Soper - BMJ open, 2015 - bmjopen.bmj.com
Objective There is a widely held assumption that engagement by clinicians and healthcare
organisations in research improves healthcare performance at various levels, but little direct …

If health organisations and staff engage in research, does healthcare improve? Strengthening the evidence base through systematic reviews

A Boaz, B Goodenough, S Hanney, B Soper - Health Research Policy and …, 2024 - Springer
Background There is an often-held assumption that the engagement of clinicians and
healthcare organizations in research improves healthcare performance at various levels …

Disparities in breast cancer treatment and outcomes: biological, social, and health system determinants and opportunities for research

SB Wheeler, KE Reeder‐Hayes, LA Carey - The oncologist, 2013 - academic.oup.com
Racial disparities in breast cancer mortality have been widely documented for several
decades and persist despite advances in receipt of mammography across racial groups …

Research activity and the association with mortality

BA Ozdemir, A Karthikesalingam, S Sinha… - PloS one, 2015 - journals.plos.org
Introduction The aims of this study were to describe the key features of acute NHS Trusts
with different levels of research activity and to investigate associations between research …

Impact of care at comprehensive cancer centers on outcome: results from a population‐based study

JA Wolfson, CL Sun, LP Wyatt, A Hurria, S Bhatia - Cancer, 2015 - Wiley Online Library
BACKGROUND Rigorous processes ensure quality of research and clinical care at National
Cancer Institute‐designated comprehensive cancer centers (NCICCCs). Unmeasurable …

Disparities in use of human epidermal growth hormone receptor 2–targeted therapy for early-stage breast cancer

K Reeder-Hayes, S Peacock Hinton, K Meng… - Journal of Clinical …, 2016 - ascopubs.org
Purpose Trastuzumab is a key component of adjuvant therapy for stage I to III human
epidermal growth factor receptor 2 (HER2)–positive breast cancer. The rates and patterns of …

Preoperative breast MRI and surgical outcomes in elderly women with invasive ductal and lobular carcinoma: a population-based study

AK Fortune-Greeley, SB Wheeler, AM Meyer… - Breast cancer research …, 2014 - Springer
Existing evidence suggests that preoperative breast magnetic resonance imaging (MRI)
might not improve surgical outcomes in the general breast cancer population. To determine …

Racial disparities in time to treatment persist in the setting of a comprehensive breast center

S Zaveri, D Nevid, M Ru, E Moshier, K Pisapati… - Annals of surgical …, 2022 - Springer
Background Racial disparities in breast cancer care have been linked to treatment delays.
We explored whether receiving care at a comprehensive breast center could mitigate …

Breast cancer disparities at home and abroad: a review of the challenges and opportunities for system-level change

KE Reeder-Hayes, BO Anderson - Clinical Cancer Research, 2017 - AACR
Sizeable disparities exist in breast cancer outcomes, both between Black and White patients
in the United States, and between patients in the United States and other high-income …

Creating a “culture of research” in a community hospital: Strategies and tools from the National Cancer Institute Community Cancer Centers Program

EP Dimond, D St. Germain, LM Nacpil… - Clinical …, 2015 - journals.sagepub.com
Background The value of community-based cancer research has long been recognized. In
addition to the National Cancer Institute's Community Clinical and Minority-Based Oncology …